Published in J Thromb Haemost on April 01, 2006
Exercise Training After an Acute Blood Clot (TRAIN ABC) | NCT01864447
Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90
Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol (2011) 1.51
Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis (2009) 1.18
Contemporary issues in the prevention and management of postthrombotic syndrome. Ann Pharmacother (2009) 0.79
Multifaceted management of the postthrombotic syndrome. Semin Intervent Radiol (2012) 0.76
Medical Treatment for Postthrombotic Syndrome. Semin Intervent Radiol (2017) 0.75
Long-Term Results of Catheter-Directed Thrombolysis Combined with Iliac Vein Stenting for Iliofemoral Deep Vein Thrombosis. Vasc Specialist Int (2015) 0.75
Compression Therapy in the Prevention of Postthrombotic Syndrome: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.75
Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet (2000) 2.74
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet (1999) 2.46
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med (1992) 2.23
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
The epidemiology of road accidents in childhood. Am J Public Health (1987) 2.12
Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med (2000) 2.12
Real-world variability in dabigatran levels in patients with atrial fibrillation. J Thromb Haemost (2015) 2.07
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation (2004) 2.05
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med (1997) 2.04
Side effects of hyperbaric oxygen therapy in children with cerebral palsy. Undersea Hyperb Med (2006) 2.03
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med (1998) 2.03
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med (2001) 1.93
Does this patient have deep vein thrombosis? JAMA (1998) 1.90
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med (2000) 1.70
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med (2001) 1.70
Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med (2001) 1.68
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67
Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg (2001) 1.60
A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost (2006) 1.59
The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med (1998) 1.58
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530. Bioorg Med Chem Lett (1998) 1.54
Seasonal variation in deep vein thrombosis. BMJ (1996) 1.52
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost (2007) 1.51
Symptomatic hypocalcemia from oral sodium phosphate: a report of two cases. Am J Gastroenterol (1998) 1.46
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med (1996) 1.45
Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb Haemost (1991) 1.45
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. J Thromb Haemost (2011) 1.42
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology (2012) 1.41
Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest (2001) 1.39
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem (1994) 1.38
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost (2008) 1.33
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
Venous thromboembolism in patients undergoing rehabilitation for stroke. Arch Phys Med Rehabil (1992) 1.26
Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med (1992) 1.24
The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review. Br J Ophthalmol (2008) 1.24
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med (2000) 1.24
Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Haemostasis (2000) 1.22
Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg (2003) 1.21
Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. Int Angiol (1999) 1.16
Coordination of primary health care for back pain. A randomized controlled trial. Spine (Phila Pa 1976) (2000) 1.16
D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med (1997) 1.14
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. Osteoarthritis Cartilage (2008) 1.11
Program description: a hospitalist-run, medical short-stay unit in a teaching hospital. CMAJ (2000) 1.10
Risk of infectious diseases in children attending different types of day-care setting. Epicrèche Research Group. Respiration (1994) 1.09
Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med (1998) 1.08
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med (1994) 1.08
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys (1999) 1.08
Evaluation of the Confusion Assessment Method (CAM) as a screening tool for delirium in the emergency room. Gen Hosp Psychiatry (2001) 1.07
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost (2005) 1.06
Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med (1998) 1.06
Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost (2011) 1.06
Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler (2007) 1.06
Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol (1985) 1.04
Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child (1976) 1.04
Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower-limb venous compression ultrasonography? Arch Intern Med (2000) 1.03
The Juvenile Arthritis Quality of Life Questionnaire--development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol (1997) 1.03
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost (2007) 1.02
The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc (1997) 1.01
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med (1992) 1.00
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost (1991) 1.00
The management of a sub-segmental pulmonary embolism: a cross-sectional survey of Canadian thrombosis physicians. J Thromb Haemost (2011) 1.00
The role of D-dimer in the diagnosis of venous thromboembolism. Curr Opin Pulm Med (1997) 0.99
Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial. J Thromb Haemost (2015) 0.99
A latex D-dimer reliably excludes venous thromboembolism. Arch Intern Med (2001) 0.97
Development and validation of an instrument for measuring appointment-specific client satisfaction in companion-animal practice. Prev Vet Med (2009) 0.97
Type of day-care setting and risk of repeated infections. Pediatrics (1994) 0.97
Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med (2002) 0.97
Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group. Pediatr Infect Dis J (1993) 0.97
Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy. Blood Coagul Fibrinolysis (2002) 0.97
The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons. J Neurosci (1996) 0.96
Hodgkin's Disease 1985. Can Fam Physician (1985) 0.96
Direct and indirect costs of management of long-term warfarin therapy in Canada. J Thromb Haemost (2010) 0.95
A guide to GRADE guidelines for the readers of JTH. J Thromb Haemost (2013) 0.94
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med (2000) 0.94
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromb Haemost (2005) 0.94
Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res (1993) 0.93
D-dimer testing in pregnant patients: towards determining the next 'level' in the diagnosis of deep vein thrombosis. J Thromb Haemost (2010) 0.93
Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med (1998) 0.93
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med (1998) 0.93
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. J Thromb Haemost (2003) 0.92
Uses of heparin. Ancrod for heparin induced thrombocytopenia. BMJ (1993) 0.92